RBM39 has been shown to be essential for cancer cell survival both in vitro and in vivo, with the degradation of RBM39 leading to anti-tumoral effects across many cancer cell lines and xenograft models [12,15,28,29,30,31]. Here, RBM39 is linked to cancer.